Yasunari Kishino

Hatanodai, 1428666, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Klebsiella pneumoniae Septic Pulmonary Embolism from Renal Vein Thrombosis.

Klebsiella pneumoniae Septic Pulmonary Embolism from Renal Vein Thrombosis.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: June 21, 2026

Comparative Efficacy of ALK Inhibitors for Treatment-Naïve ALK-Positive Advanced Non-Small Cell Lung Cancer with Central Nervous System Metastasis: A Network Meta-Analysis.

Comparative Efficacy of ALK Inhibitors for Treatment-Naïve ALK-Positive Advanced Non-Small Cell Lung Cancer with Central Nervous System Metastasis: A Network Meta-Analysis.

Journal: International journal of molecular sciences

Published: December 23, 2022

Mechanisms of EGFR-TKI-Induced Apoptosis and Strategies Targeting Apoptosis in EGFR-Mutated Non-Small Cell Lung Cancer.

Mechanisms of EGFR-TKI-Induced Apoptosis and Strategies Targeting Apoptosis in EGFR-Mutated Non-Small Cell Lung Cancer.

Journal: Genes

Published: October 18, 2022

Diverse Mechanisms of Resistance against Osimertinib, a Third-Generation EGFR-TKI, in Lung Adenocarcinoma Cells with an EGFR-Activating Mutation.

Diverse Mechanisms of Resistance against Osimertinib, a Third-Generation EGFR-TKI, in Lung Adenocarcinoma Cells with an EGFR-Activating Mutation.

Journal: Cells

Published: May 26, 2022

Serum cystatin C and CRP are early predictive biomarkers for emergence of hypoxia in COVID-19.

Serum cystatin C and CRP are early predictive biomarkers for emergence of hypoxia in COVID-19.

Journal: The American journal of the medical sciences

Published: August 25, 2021

Comparative Efficacy and Safety of Lorlatinib and Alectinib for ALK-Rearrangement Positive Advanced Non-Small Cell Lung Cancer in Asian and Non-Asian Patients: A Systematic Review and Network Meta-Analysis.

Comparative Efficacy and Safety of Lorlatinib and Alectinib for ALK-Rearrangement Positive Advanced Non-Small Cell Lung Cancer in Asian and Non-Asian Patients: A Systematic Review and Network Meta-Analysis.

Journal: Cancers

Published: June 26, 2021

Immune-Associated Proteins Are Enriched in Lung Tissue-Derived Extracellular Vesicles during Allergen-Induced Eosinophilic Airway Inflammation.

Immune-Associated Proteins Are Enriched in Lung Tissue-Derived Extracellular Vesicles during Allergen-Induced Eosinophilic Airway Inflammation.

Journal: International journal of molecular sciences

Published: March 24, 2021

Comparative Efficacy and Safety of Immunotherapeutic Regimens with PD-1/PD-L1 Inhibitors for Previously Untreated Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.

Comparative Efficacy and Safety of Immunotherapeutic Regimens with PD-1/PD-L1 Inhibitors for Previously Untreated Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.

Journal: Current oncology (Toronto, Ont.)

Published: January 08, 2021

Molecular and Clinical Features of EGFR-TKI-Associated Lung Injury.

Molecular and Clinical Features of EGFR-TKI-Associated Lung Injury.

Journal: International journal of molecular sciences

Published: December 23, 2020

Comparative Efficacy and Safety of Anti-PD-1/PD-L1 Immune Checkpoint Inhibitors for Refractory or Relapsed Advanced Non-Small-Cell Lung Cancer-A Systematic Review and Network Meta-Analysis.

Comparative Efficacy and Safety of Anti-PD-1/PD-L1 Immune Checkpoint Inhibitors for Refractory or Relapsed Advanced Non-Small-Cell Lung Cancer-A Systematic Review and Network Meta-Analysis.

Journal: Cancers

Published: November 18, 2020

Correlation of Arterial CO2 and Respiratory Impedance Values among Subjects with COPD.

Correlation of Arterial CO2 and Respiratory Impedance Values among Subjects with COPD.

Journal: Journal of clinical medicine

Published: July 15, 2020

Nivolumab plus Ipilimumab versus Existing Immunotherapies in Patients with PD-L1-Positive Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.

Nivolumab plus Ipilimumab versus Existing Immunotherapies in Patients with PD-L1-Positive Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.

Journal: Cancers

Published: June 19, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026